 Evan Schaefer
Concepts (72)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheters, Indwelling | 1 | 2025 | 96 | 0.880 |
Why?
| | Central Venous Catheters | 1 | 2025 | 53 | 0.880 |
Why?
| | Catheterization, Peripheral | 1 | 2025 | 120 | 0.830 |
Why?
| | Ultrasonography, Interventional | 1 | 2025 | 166 | 0.820 |
Why?
| | Catheterization, Central Venous | 1 | 2025 | 123 | 0.810 |
Why?
| | Leukemia, Myeloid, Acute | 4 | 2024 | 688 | 0.710 |
Why?
| | Carcinogenesis | 1 | 2022 | 228 | 0.620 |
Why?
| | Leukemia | 1 | 2022 | 246 | 0.600 |
Why?
| | Hemoglobinuria, Paroxysmal | 1 | 2018 | 7 | 0.550 |
Why?
| | Bone Marrow Diseases | 1 | 2018 | 20 | 0.550 |
Why?
| | Anemia, Aplastic | 1 | 2018 | 42 | 0.530 |
Why?
| | Clonal Evolution | 1 | 2018 | 47 | 0.520 |
Why?
| | Sulfonamides | 3 | 2024 | 583 | 0.470 |
Why?
| | Myelodysplastic Syndromes | 1 | 2018 | 165 | 0.460 |
Why?
| | Induction Chemotherapy | 3 | 2024 | 88 | 0.450 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 3 | 2024 | 280 | 0.400 |
Why?
| | Emergency Service, Hospital | 1 | 2025 | 2383 | 0.390 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 2399 | 0.290 |
Why?
| | Mutation | 3 | 2024 | 4090 | 0.270 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 1969 | 0.230 |
Why?
| | Time and Motion Studies | 1 | 2025 | 28 | 0.230 |
Why?
| | Equipment Design | 1 | 2025 | 525 | 0.200 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2024 | 72 | 0.200 |
Why?
| | Neoplasms, Second Primary | 1 | 2024 | 102 | 0.190 |
Why?
| | Trauma Centers | 1 | 2025 | 466 | 0.190 |
Why?
| | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 89 | 0.180 |
Why?
| | Multiple Trauma | 1 | 2021 | 121 | 0.150 |
Why?
| | Shock | 1 | 2021 | 110 | 0.150 |
Why?
| | Nuclear Proteins | 1 | 2024 | 740 | 0.150 |
Why?
| | Altitude | 1 | 2023 | 463 | 0.150 |
Why?
| | Repressor Proteins | 1 | 2022 | 429 | 0.140 |
Why?
| | Proto-Oncogene Proteins | 1 | 2022 | 625 | 0.140 |
Why?
| | Cell Cycle Proteins | 1 | 2022 | 630 | 0.130 |
Why?
| | Chromatin | 1 | 2022 | 553 | 0.130 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 693 | 0.120 |
Why?
| | Time Factors | 1 | 2025 | 7134 | 0.110 |
Why?
| | Blood Glucose | 1 | 2023 | 2344 | 0.100 |
Why?
| | Prospective Studies | 1 | 2025 | 8078 | 0.100 |
Why?
| | Gastrointestinal Microbiome | 1 | 2021 | 768 | 0.090 |
Why?
| | Aged | 3 | 2025 | 26217 | 0.080 |
Why?
| | Humans | 8 | 2025 | 145783 | 0.080 |
Why?
| | Biomarkers | 1 | 2021 | 4302 | 0.070 |
Why?
| | Inflammation | 1 | 2021 | 2884 | 0.070 |
Why?
| | Middle Aged | 3 | 2025 | 36309 | 0.070 |
Why?
| | Signal Transduction | 1 | 2022 | 5224 | 0.070 |
Why?
| | Neoplasms | 1 | 2023 | 2913 | 0.070 |
Why?
| | Adult | 3 | 2025 | 40881 | 0.060 |
Why?
| | Male | 4 | 2025 | 73011 | 0.060 |
Why?
| | Daunorubicin | 1 | 2024 | 25 | 0.050 |
Why?
| | Cytarabine | 1 | 2024 | 66 | 0.050 |
Why?
| | Peru | 1 | 2023 | 60 | 0.050 |
Why?
| | Female | 3 | 2025 | 79045 | 0.050 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 254 | 0.050 |
Why?
| | C-Peptide | 1 | 2023 | 190 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2023 | 399 | 0.040 |
Why?
| | Hydrocortisone | 1 | 2023 | 298 | 0.040 |
Why?
| | Supervised Machine Learning | 1 | 2021 | 23 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2023 | 442 | 0.040 |
Why?
| | Metagenomics | 1 | 2021 | 150 | 0.040 |
Why?
| | ROC Curve | 1 | 2021 | 618 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 849 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2021 | 508 | 0.040 |
Why?
| | Biodiversity | 1 | 2021 | 311 | 0.030 |
Why?
| | Glucose | 1 | 2023 | 1049 | 0.030 |
Why?
| | Genomics | 1 | 2023 | 830 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2024 | 17330 | 0.030 |
Why?
| | Cohort Studies | 1 | 2024 | 6033 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2024 | 8347 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2021 | 4568 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 11794 | 0.020 |
Why?
| | Mice | 1 | 2021 | 18356 | 0.010 |
Why?
| | Animals | 1 | 2021 | 38102 | 0.010 |
Why?
|
|
Schaefer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|